Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancerChaping Cheng, Helen He Zhu, Zhongzhong Ji et al.|Nature Cancer|2022Cited by 71
Abstract 917: The preclinical characterization of TST005, a bi-functional anti-PD-L1 and TGF-β trap fusion proteinHongjun Li, Yi Gu, Chunming Wang et al.|Cancer Research|2021Cited by 3
Abstract 2535: Development of Claudin 18.2 IHC 14G11 pharmDx as a clinical trial assay for the clinical development of anti-claudin 18.2 monoclonal antibody osemitamab (TST001) in gastric and gastroesophageal junction adenocarcinomaHayley Alderson, Emin Oroudjev, Katie Lefley et al.|Cancer Research|2024Cited by 2